New study explores how CF drugs change sinus bacteria and smell
NCT ID NCT05982795
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study looks at how CFTR modulator therapy affects the nose and sinuses in adults with cystic fibrosis. Researchers will compare bacterial communities, inflammation, sense of smell, and quality of life between patients on the therapy and those not on it. Participants provide nasal samples, take smell tests, and fill out surveys. The goal is to understand how this therapy impacts chronic sinus problems.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CFTR modulator therapy
- What this could lead to
- If successful, this study could reveal how CFTR modulators improve sinus health and quality of life in cystic fibrosis, guiding better management of chronic sinus disease.
- What could go wrong
- This is a small observational study (30 participants) comparing two groups, not a controlled trial. Results may not apply to all CF patients, and no new treatment is being tested.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dartmouth-Hitchcock Medical Center
RECRUITINGLebanon, New Hampshire, 03756, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a peer coach help young people take control of their chronic illness?
- Could a single antibiotic be enough for cystic fibrosis lung infections?
- Early use of powerful CF drugs may boost growth in young children
- Hands-On therapy may soothe cystic fibrosis pain without drugs
- Newborn screening study aims to catch rare diseases at birth
- Breath sniffing may reveal early clues to cystic fibrosis drug success